Barclays PLC Biolife Solutions Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Barclays PLC holds 64,423 shares of BLFS stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,423

Previous 64,423 -0.0%

Holding current value

$1.61 Million

Previous $1.61 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$19.19 - $26.52 $207,309 - $286,495	10,803 Added 20.15%	64,423 $1.61 Million
Q2 2024 Aug 14, 2024	BUY	$15.14 - $22.99 $84,269 - $127,962	5,566 Added 11.58%	53,620 $1.15 Million
Q1 2024 May 15, 2024	SELL	$15.35 - $18.82 $721,971 - $885,179	-47,034 Reduced 49.46%	48,054 $892,000
Q4 2023 Feb 15, 2024	BUY	$8.99 - $16.86 $342,698 - $642,703	38,120 Added 66.91%	95,088 $1.55 Million
Q3 2023 Nov 07, 2023	BUY	$10.81 - $22.96 $414,141 - $879,620	38,311 Added 205.34%	56,968 $787,000
Q2 2023 Aug 03, 2023	BUY	$17.19 - $24.34 $20,576 - $29,134	1,197 Added 6.86%	18,657 $412,000
Q1 2023 May 04, 2023	BUY	$17.67 - $26.07 $18,553 - $27,373	1,050 Added 6.4%	17,460 $380,000
Q4 2022 Feb 13, 2023	BUY	$16.95 - $25.07 $128,701 - $190,356	7,593 Added 86.12%	16,410 $299,000
Q3 2022 Nov 03, 2022	SELL	$14.64 - $26.7 $12,458 - $22,721	-851 Reduced 8.8%	8,817 $201,000
Q2 2022 Aug 12, 2022	SELL	$10.54 - $24.2 $117,310 - $269,346	-11,130 Reduced 53.51%	9,668 $133,000
Q1 2022 May 16, 2022	BUY	$20.81 - $37.29 $114,350 - $204,908	5,495 Added 35.91%	20,798 $472,000
Q4 2021 Feb 14, 2022	SELL	$32.99 - $58.55 $581,481 - $1.03 Million	-17,626 Reduced 53.53%	15,303 $570,000
Q3 2021 Nov 09, 2021	BUY	$42.03 - $60.5 $1.25 Million - $1.81 Million	29,840 Added 966.01%	32,929 $1.39 Million
Q2 2021 Aug 13, 2021	SELL	$29.51 - $44.62 $425,858 - $643,911	-14,431 Reduced 82.37%	3,089 $137,000
Q1 2021 May 13, 2021	BUY	$32.95 - $44.24 $427,723 - $574,279	12,981 Added 285.99%	17,520 $630,000
Q4 2020 Feb 11, 2021	SELL	$27.5 - $45.75 $48,262 - $80,291	-1,755 Reduced 27.88%	4,539 $181,000
Q3 2020 Nov 12, 2020	BUY	$16.04 - $28.94 $36,507 - $65,867	2,276 Added 56.65%	6,294 $182,000
Q2 2020 Aug 12, 2020	BUY	$9.2 - $17.06 $14,508 - $26,903	1,577 Added 64.6%	4,018 $66,000
Q1 2020 May 13, 2020	SELL	$8.36 - $17.03 $40,286 - $82,067	-4,819 Reduced 66.38%	2,441 $23,000
Q4 2019 Feb 10, 2020	BUY	$14.59 - $18.9 $5,850 - $7,578	401 Added 5.85%	7,260 $117,000
Q3 2019 Nov 14, 2019	SELL	$15.7 - $20.98 $59,518 - $79,535	-3,791 Reduced 35.6%	6,859 $114,000
Q2 2019 Aug 14, 2019	SELL	$15.2 - $19.42 $523,837 - $669,271	-34,463 Reduced 76.39%	10,650 $181,000
Q1 2019 May 15, 2019	SELL	$10.9 - $21.26 $302,878 - $590,751	-27,787 Reduced 38.12%	45,113 $807,000
Q4 2018 Feb 14, 2019	BUY	$9.5 - $17.17 $688,750 - $1.24 Million	72,500 Added 18125.0%	72,900 $877,000
Q3 2018 Nov 14, 2018	BUY	$14.99 - $25.48 $5,996 - $10,192	400 New	400 $7,000

Others Institutions Holding BLFS

# of Institutions

199

Shares Held

45M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.07B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account